Quest Diagnostics Incorporated
Quest Diagnostics Incorporated
Quest Diagnostics Incorporated
DGX
DGX
NYSE
Health Services
Services to the Health Industry
227.86
USD
-0.04
-0.02%
Fechado: 07-24 20:00 (UTC+0)
227.86
USD
+0
+0.00%
Pós-fechamento: 07-25 00:00 (UTC+0)

DGX Estatísticas principais

Alta
233.21
Abrir
228.00
Volume
1.54M
Baixa
223.42
Fechamento anterior
227.90
Valor negociado
353.86M
52 sem. máx.
237.78
Vol. relativo
1.414
Amplitude (%)
4.30%
52 sem. mín.
165.78
Taxa de giro
1.39%
Cap. de Mercado
25.14B
P/L (TTM)
24.17
P/L (Anual)
25.689
P/VP
3.35
P/S
2.18
Lucro por ação (EPS)
9.427
Dividendo (TTM)
3.737
Rendimento de dividendos
1.44%
Ações em circulação
110.69M
Unidade monetária
USD

DGX Desempenho de Preço

7 dia
30 dia
90 dia
180 dia
No acumulado do ano
1 Ano
DGX Distribuição do fluxo de dinheiro
DGX Volume diário de venda a descoberto
DGX Histórico de short interest
As of 2026-07-26, the Quest Diagnostics Incorporated (DGX) stock price today is 227.86. Based on this price, the company has a market capitalization of $25.14B, with a P/E ratio of 24.17. On 2026-07-26, DGX traded between 223.42 and 233.21. Today’s stock price is 1.99% above the daily low and 2.29% below the daily high, placing DGX perto do meio de its most recent trading range. Trading volume currently stands at 1.54M, compared with an average daily volume of 1.09M. This suggests that trading activity is acima do nível habitual than usual. Over the past year, Quest Diagnostics Incorporated shares have traded between 165.78 and 237.78. At today’s price, DGX is 37.45% above its 52-week low and 4.17% below its 52-week high.
Nome empresa
Quest Diagnostics Incorporated
Setor
Health Services
Indústria
Services to the Health Industry
Trocas
NYSE
Número de funcionários
57,000
Tamanho do lote
100
Unidade monetária
USD
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

DGX FAQ

Pesquisar
Mais